Escherichia coli bacteraemia in adults: Age-related differences in clinical and bacteriological characteristics, and outcome

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2672-2683

  Roubaud Baudron, C ^a,b,c   Panhard, X ^b,c,d   Clermont, O ^b,c   Mentre F ^b,c,d   Fantin, B ^b,c,e   Denamur, E ^b,c   Lefort, A ^b,c,e   Wolff, Michel ^d   Alavoine, Loubna ^d   Duval, Xavier ^d   Skurnik, David ^d   Woerther, Paul Louis ^d   Andremont, Antoine ^d   Carbonnelle, Etienne ^f   Lortholary, Olivier ^f   Nassif, Xavier ^f   Abgrall, Sophie ^g   Jaureguy, Françoise ^g   Picard, Bertrand ^g   Houdouin, Véronique ^h   Aujard, Yannick ^h   Bonacorsi, Stéphane ^h   Bingen, Edouard ^h   Meybeck, Agnès ⁱ   Barnaud, Guilène ⁱ   Branger, Catherine ⁱ   Lefort, Agnès ^e   Fantin, Bruno ^e   Bellier, Claire ^e   Bert, Frédéric ^e   Nicolas Chanoine, Marie Hélène ^e   Page, Bernard ^j   Cremniter, Julie ^j   Gaillard, Jean Louis ^j   Garo, Bernard ^k   Ansart, Séverine ^k   Herry Arnaud, Geneviève ^k   Tandé, Didier ^k   Renet, Jean Claude ^l   Bekolo, René Ze ^l   Verdon, Renaud ^l   Leclercq, Roland ^l   De Gialluly, Claire ^m   Besnier, Jean Marc ^m   Mereghetti, Laurent ^m   Quentin, Roland ^m   Kouatchet, Achille ⁿ   Mercat, Alain ⁿ   Joly Guillou, Marie Laure ⁿ   Dalebroux, Catherine ^o   Chavanet, Pascal ^o   Neuwirth, Catherine ^o   Colliard, Camille ^p   Dary, Martin ^p   Potel, Gilles ^p   Caillon, Jocelyne ^p   Leturdu, Françoise ^q   Sollet, Jean Pierre ^q   Plantefève, Gaëtan ^q   De Patureaux, Agnès ^r   Tattevin, Pierre ^r   Donnio, Pierre Yves ^r   Denamur, Erick ^s   Clermont, Olivier ^s   Amorin, Christine ^s   Glodt, Jeremy ^s   Lassel, Ludovic ^d   Dornic, Quentin ^d   Marcault, Estelle ^t   Tubach, Florence ^t   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g AVICENNE HOSPITAL   (France)

^h HÔPITAL ROBERT DEBRÉ   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j HÔPITAL AMBROISE PARÉ   (France)

^k BREST UNIVERSITY HOSPITAL   (France)

^l CAEN UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY HOSPITAL OF TOURS   (France)

ⁿ ANGERS UNIVERSITY HOSPITAL   (France)

^o DIJON UNIVERSITY HOSPITAL   (France)

^p NANTES UNIVERSITY HOSPITAL   (France)

^q Argenteuil Hospital   (France)

^r RENNES UNIVERSITY HOSPITAL   (France)

^s INSERM   (France)

^t CHU Rennes ^*  (France)

more..

Author keywords

Bacteraemia; elderly; Escherichia coli; mortality and virulence factors

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; BACTEREMIA; CLINICAL TRIAL; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84922255811     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000211     Document Type: Article

References (48)

1. Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001; 29: 1303-1310.
2. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Critical Care Medicine 2006; 34: 15-21.
3. Gavazzi G, Krause KH. Ageing and infection. Lancet Infectious Diseases 2002; 2: 659-666.
4. Girard TD, Ely EW. Bacteremia and sepsis in older adults. Clinics in Geriatric Medicine 2007; 23: 633-647.
5. Marik PE, Zaloga GP. The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators. Journal of the American Geriatrics Society 2001; 49: 5-9.
6. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clinical Infectious Diseases 2005; 41: S504-512.
7. Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. American Journal of Clinical Nutrition 1997; 66: 478S-484S.
8. Nicolle LE. Urinary tract infections in long-term-care facilities. Infection Control and Hospital Epidemiology 2001; 22: 167-175.
9. Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs & Aging 1997; 11: 7-18.
10. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia- Sepsis Study Group. American Journal of Respiratory and Critical Care Medicine 1996; 154: 617-624.
11. Laupland KB, et al. Severe bloodstream infections: a population-based assessment. Critical Care Medicine 2004; 32: 992-997.
12. Chassagne P, et al. Is presentation of bacteremia in the elderly the same as in younger patients? American Journal of Medicine 1996; 100: 65-70.
13. Leibovici L, et al. Bloodstream infections in patients older than eighty years. Age and Ageing 1993; 22: 431-442.
14. Crane SJ, Uslan DZ, Baddour LM. Bloodstream infections in a geriatric cohort: a population-based study. American Journal of Medicine 2007; 120: 1078-1083.
15. Diekema DJ, Pfaller MA, Jones RN. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997- 2000. International Journal of Antimicrobial Agents 2002; 20: 412-418.
16. Lefort A, et al. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. Journal of Clinical Microbiology 2011; 49: 777-783.
17. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology 2000; 66: 4555-4558.
18. Clermont O, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M- 15-producing strains. Journal of Antimicrobial Chemotherapy 2009; 64: 274-277.
19. Clermont O, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. Journal of Antimicrobial Chemotherapy 2008; 61: 1024-1028.
20. Skurnik D, et al. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrobial Agents and Chemotherapy 2005; 49: 3062-3065.
21. Hacker J, et al. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Molecular Microbiology 1997; 23: 1089-1097.
22. Bingen-Bidois M, et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infection and Immunity 2002; 70: 3216-3226.
23. Huang SH, et al. A novel genetic island of meningitic Escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-sourceregulated invasion of human brain microvascular endothelial cells. Functional & Integrative Genomics 2001; 1: 312-322.
24. Kurazono H, et al. Characterization of a putative virulence island in the chromosome of uropathogenic Escherichia coli possessing a gene encoding a uropathogenic-specific protein. Microbial Pathogenesis 2000; 28: 183-189.
25. Sogaard M, et al. Short-term mortality in relation to age and comorbidity in older adults with communityacquired bacteremia: a population-based cohort study. Journal of the American Geriatrics Society 2008; 56: 1593-1600.
26. Picard B, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infection and Immunity 1999; 67: 546-553.
27. Kennedy KJ, Roberts JL, Collignon PJ. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Medical Journal of Australia 2008; 188: 209-213.
28. McCue JD. Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology, and mortality. Journal of the American Geriatrics Society 1987; 35: 213-218.
29. Ismail NH, et al. Bacteraemia in the elderly. Annals of the Academy of Medicine (Singapore) 1997; 26: 593-598.
30. Gavazzi G, et al. Bloodstream infection: differences between young-old, old, and old-old patients. Journal of the American Geriatrics Society 2002; 50: 1667-1673.
31. Greenberg BM, et al. Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital. Journal of Infection 2005; 50: 288-295.
32. Lee CC, et al. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine 2007; 86: 138-144.
33. Lark RL, et al. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagnostic Microbiology and Infectious Disease 2001; 41: 15-22.
34. Shmuely H, et al. Prediction of mortality in patients with bacteremia: the importance of pre-existing renal insufficiency. Renal Failure 2000; 22: 99-108.
35. Nicolas-Chanoine MH, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2008; 61: 273-281.
36. Banerjee R, et al. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infection Control and Hospital Epidemiology 2013; 34: 361-369.
37. Russo TA, Carlino UB, Johnson JR. Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infection and Immunity 2001; 69: 6209-6216.
38. Srinivasan U, Foxman B, Marrs CF. Identification of a gene encoding heat-resistant agglutinin in Escherichia coli as a putative virulence factor in urinary tract infection. Journal of Clinical Microbiology 2003; 41: 285-289.
39. Jaureguy F, et al. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clinical Microbiology and Infection 2007; 13: 854-862.
40. Laupland KB, et al. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clinical Microbiology and Infection 2008; 14: 1041-1047.
41. Martinez JA, et al. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. Journal of Clinical Microbiology 2006; 44: 1468-1474.
42. Picard B, Goullet P. Correlation between electrophoretic types B1 and B2 of carboxylesterase B and host-dependent factors in Escherichia coli septicaemia. Epidemiology and Infection 1988; 100: 51-61.
43. Whitelaw DA, Rayner BL, Willcox PA. Communityacquired bacteremia in the elderly: a prospective study of 121 cases. Journal of the American Geriatrics Society 1992; 40: 996-1000.
44. Courpon-Claudinon A, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clinical Microbiology and Infection 2011; 17: 557-565.
45. Banerjee R, et al. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrobial Agents and Chemotherapy 2013; 57: 5912-5917.
46. Warren-Gash C, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. Journal of Infectious Diseases 2012; 206: 1652-1659.
47. Robbins JA, Biggs ML, Cauley J. Adjusted mortality after hip fracture: from the cardiovascular health study. Journal of the American Geriatrics Society 2006; 54: 1885-1891.
48. Mahjoub H, et al. Long-term survival in patients older than 80 years hospitalised for heart failure. A 5-year prospective study. European Journal of Heart Failure 2008; 10: 78-84.